Darexaban Maleate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDarexaban Maleate
Drug Alias NameDarexaban马来酸达瑞沙班Tanexaban maleate马来酸他奈沙班达瑞沙班 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous ThromboembolismThromboembolismAcute Coronary Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[48] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Tokai Co LtdAstellas Pharma Europe BvAstellas Pharma Inc +[4] 
Active IndicationsN/A
Inactive IndicationsVenous ThromboembolismThromboembolismAcute Coronary Syndrome +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG